-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience Q1 EPS $(0.32) Misses $(0.31) Estimate

Benzinga·05/11/2026 20:05:11
Listen to the news
Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent decrease over losses of $(0.28) per share from the same period last year.